Yurogen Biosystems
Pre-clinicalYurogen Biosystems is an international biotech company dedicated to monoclonal antibody development. We were established in Boston, Massachusetts in 2014. In 2018, Yurogen set up a Chinese branch in Wuhan China to expand CRO services in East Asia. In 2021, we merged with ABclonal Science Inc, a growing provider of biological reagents and services in the global market.
About
Yurogen Biosystems is an international biotech company dedicated to monoclonal antibody development. We were established in Boston, Massachusetts in 2014. In 2018, Yurogen set up a Chinese branch in Wuhan China to expand CRO services in East Asia. In 2021, we merged with ABclonal Science Inc, a growing provider of biological reagents and services in the global market.
Funding History
1Total raised: $1.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile